Contemporary Topics in Thyroid Cancer

This program happened in the past, and no dates are currently scheduled.

Select this button to navigate the sections of this page

Conference ID

C6300

Purpose

Since the early 1970s, the incidence of thyroid cancer has more than doubled, and the current national disease prevalence is estimated at 300,000 affected people. Approximately 39,000 new cases of thyroid carcinoma will be diagnosed in the United States annually, with 1,590 deaths from the disease.

Clinicians and researchers have recently gained an increased understanding of the biology of thyroid cancers. Concurrently, the availability of multiple novel molecular agents with the potential to impact the disease has resulted in the launch of several ongoing clinical studies evaluating the role of medical management for locally advanced or disseminated thyroid cancer. Exciting early efficacy and safety findings have been presented to the oncology community, offering new hope of beneficial treatments for patients with no prior therapeutic opportunity. In order to offer optimal patient care — including the option of clinical trial participation — the practicing clinician must be well informed of these advances. By providing access to the latest research developments and expert perspectives on the disease, this CME program assists clinicians in the formulation of up-to-date clinical management strategies.

Audience

The audience for this program includes otolaryngologists, endocrine surgeons, general surgeons, endocrinologists, medical oncologists, radiation oncologists, primary care physicians, surgical oncologists, medical and surgical residents and fellows, physician assistants and nurse practitioners.

Objectives

  • Describe the increasing incidence, long-term natural history and molecular characteristics of thyroid cancer.
  • Develop an evaluation and treatment algorithm for localized and advanced thyroid cancer across the age spectrum.
  • Discuss the significant resource and financial burden of thyroid cancer on the health-care system.
  • Develop a clinical algorithm for the management of early and advanced thyroid cancer, including the roles of surgery, 131I and thyroxine therapy, radiation therapy and chemotherapy.
  • Recognize the acute and chronic side effects of radioactive iodine treatment and identify the clinical and laboratory signs of iodine-refractory thyroid cancer.
  • Discuss the etiology and management strategies of voice dysfunction following thyroid surgery.
  • Review the emerging data on the genetics of familial thyroid cancer and the implications for presymptomatic diagnosis.
  • Recognize the clinical significance of recent changes in the understanding of thyroid cancer pathology.

Credit

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Agenda

  • 11:30 a.m. | Check-In and Buffet Luncheon
  • Noon | Welcome
    Peter Dillon, MD, FACS
  • 12:05 p.m. | Course Overview and Objectives
    Brian Saunders, MD, FACS
    David Goldenberg, MD, FACS
    Melissa Boltz, DO, MBA, FACS
  • 12:15 p.m. | Evaluating the Thyroid Nodule
    Andrea Manni, MD
  • 12:40 p.m. | Surgical Management of Thyroid Cancer
    Melissa Boltz, DO, MBA, FACS
  • 1:05 p.m. | Thyroid Cancer Survivorship
    David Goldenberg, MD, FACS
  • 1:30 p.m. | Iodine Therapy for Thyroid Cancer
    Joseph Fotos, MD
  • 1:55 p.m. | Panel: Thyroid Cancer Survivors
    Moderator: Janice Schan
    Panelists: TBD
  • 2:40 p.m. | Break and Exhibits
  • 2:55 p.m. | Complications of Thyroid Surgery
    Guy Slonimsky, MD
  • 3:20 p.m. | The Treatment of Aggressive Variants of Thyroid Cancer
    Brian Saunders, MD, FACS
  • 3:45 p.m. | Contemporary Management of Thyroid Cancer Metastases
    Diane Hershock, MD, PhD
    Associate Professor of Medicine
  • 4:10 p.m. | Panel: Questions for the Experts
    Moderator: Melissa Boltz, DO, MBA, FACS
    Panelists: Joseph Fotos, MD; Diane Hershock, MD, PhD; Andrea Manni, MD; Brian Saunders, MD, FACS
  • 4:50 p.m. | Program Evaluation and Adjournment

Faculty

Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Melissa Boltz, DO, MBA, FACS
Assistant Professor of Surgery
Division of Trauma, Acute Care and Critical Care Surgery

Peter Dillon, MD, FACS
John A. and Marian T. Waldhausen Professor of Surgery
Chair, Department of Surgery
Executive Vice President, Penn State Health
Vice Dean for Clinical Affairs, Penn State College of Medicine

Joseph Fotos, MD
Assistant Professor of Radiology
Division of Nuclear Medicine

David Goldenberg, MD, FACS
Steven and Sharon Baron Professor of Surgery
Chief, Division of Otolaryngology, Head and Neck Surgery

Diane Hershock, MD, PhD
Associate Professor of Medicine
Division of Hematology/Oncology
Penn State Cancer Institute

Andrea Manni, MD
Professor of Medicine
Chief, Division of Endocrinology, Diabetes and Metabolism

Brian Saunders, MD, FACS
Associate Professor of Surgery and Medicine
Division of General Surgery Specialties and Surgical Oncology

Guy Slonimsky, MD
Instructor in Surgery
Division of Otolaryngology, Head and Neck Surgery

Course Directors

Melissa Boltz, DO, MBA, FACS
Assistant Professor of Surgery
Division of Trauma, Acute Care and Critical Care Surgery

David Goldenberg, MD, FACS
Steven and Sharon Baron Professor of Surgery
Chief, Division of Otolaryngology, Head and Neck Surgery

Brian Saunders, MD, FACS
Associate Professor of Surgery and Medicine
Division of General Surgery Specialties and Surgical Oncology

Fee

Fee is $50 per person.

There is no fee for medical students and residents; to register with no fee, send verification of student/resident status to ContinuingEd@pennstatehealth.psu.edu or fax to 717-531-5604.

Fee includes cost of instruction, refreshments, lunch and online handouts.

Registrations received after Sept. 6, 2018, will incur a $25 late fee.

Cancellation

Cancellations received later than Aug. 30, 2018, will incur a $25 processing fee.

No refunds will be given after Sept. 3, 2018.

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund registration fees but cannot be held responsible for any related costs, charges, or expenses, including cancellation/change charges assessed by airlines or travel agencies. Preregistered participants will be notified if a program is filled or canceled.

Accommodations

Accommodations are the responsibility of the program participant. See a list of Hershey-area lodging here.

Sponsor

This program is a continuing education service of Penn State College of Medicine and the Department of Surgery.

Access (ADA)

Penn State encourages persons with disabilities to participate in its programs and activities. If you anticipate needing any type of special accommodation or have questions about the physical access provided, please contact Continuing Education at least one week in advance of your participation or visit.

Changes

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

Disclosure and Conflict of Interest (COI and educational balance)

It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission, and employment without regard to personal characteristics not related to ability, performance, or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity, or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment, or retaliation against faculty, staff, or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; tel 814-863-0471/TTY. US M.Ed. C6300

Jump to ...